The Activation Pattern of the Antioxidant Enzymes in the Right Ventricle of Rat in Response to Pressure Overload is of Heart Failure Type
Overview
Affiliations
In the left ventricle subjected to pressure overload activity, the antioxidant enzymes increased at the hyperfunctional stage. During the transition to heart failure, these enzymes are down-regulated, oxidative stress increases, and apoptosis progresses. Maladaptative activation of the antioxidant enzymes at an early stage may contribute to the intrinsic vulnerability of right ventricle to pressure overload. The authors studied changes in expression and activity of the enzymes manganese and copper-zinc superoxide dismutases, glutathione peroxidase, and catalase in the right ventricle of rat following induction of pulmonary hypertension by injection of monocrotaline. Increase in the manganese superoxide dismutase was delayed to the late failing stage, activity of glutathione peroxidase was depressed throughout, and only catalase was activated at the early stage before returning to control levels. This inability to activate antioxidant enzymes may contribute to the deleterious consequences of pressure overload on right ventricle systolic function.
Association between biomarkers of zinc and copper status and heart failure: a meta-analysis.
Liu R, Yao J, Chen K, Peng W ESC Heart Fail. 2024; 11(5):2546-2556.
PMID: 38690587 PMC: 11424300. DOI: 10.1002/ehf2.14837.
GDF15 and Cardiac Cells: Current Concepts and New Insights.
Rochette L, Dogon G, Zeller M, Cottin Y, Vergely C Int J Mol Sci. 2021; 22(16).
PMID: 34445593 PMC: 8396208. DOI: 10.3390/ijms22168889.
Lack of Contribution of p66shc to Pressure Overload-Induced Right Heart Hypertrophy.
Hirschhauser C, Sydykov A, Wolf A, Esfandiary A, Bornbaum J, Kutsche H Int J Mol Sci. 2020; 21(24).
PMID: 33302436 PMC: 7762598. DOI: 10.3390/ijms21249339.
Right ventricular phenotype, function, and failure: a journey from evolution to clinics.
Taverne Y, Sadeghi A, Bartelds B, Bogers A, Merkus D Heart Fail Rev. 2020; 26(6):1447-1466.
PMID: 32556672 PMC: 8510935. DOI: 10.1007/s10741-020-09982-4.
Cardioprotection in right heart failure.
Boengler K, Schluter K, Schermuly R, Schulz R Br J Pharmacol. 2020; 177(23):5413-5431.
PMID: 31995639 PMC: 7680005. DOI: 10.1111/bph.14992.